TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23013357

Group type: EXPERIMENTAL
Intervention: Insulin detemir (0.4 U/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Neutral protamine lispro (NPL) (0.4 U/kg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 30

Group type: COMPARATOR
Intervention: Neutral protamine lispro (NPL)
Number of subjects: 30
Study: 20453635

Group type: COMPARATOR
Intervention: Standard gemcitabine monotherapy (1250 mg/m in 20-30 min on days 1 and 8)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Low-dose gemcitabine in long infusion (200 mg/m in 6 h on day 1) and cisplatin (60 mg/m on day 2)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Standard gemcitabine monotherapy
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Low-dose gemcitabine and cisplatin
Number of subjects: 112
Study: 18332309

Group type: EXPERIMENTAL
Intervention: SNJ-1656 0.003%
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: SNJ-1656 0.01%
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: SNJ-1656 0.03%
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: SNJ-1656 0.05%
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: SNJ-1656 0.1%
Number of subjects: 81
Study: 17161049

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 4687

Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 4687
Study: 14573335

Group type: COMPARATOR
Intervention: Intensive control group (IC) with a target BP of <130/85 mm Hg (n = 71)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Moderate control group (MC) with a target BP of <140/90 mm Hg (n = 69)
Number of subjects: 140
Study: 11223731

Group type: EXPERIMENTAL
Intervention: Intensified nutritional support (energy-rich diet planned for 10 MJ/day, 45-50% energy from fat)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Regular nutritional support (normal hospital diet planned for 8.5-9 MJ/day, 30-35% energy from fat)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Normal diet for normal-weight patients (group 3)
Number of subjects: 42
Study: 9220210

Group type: EXPERIMENTAL
Intervention: Doxazosin (mean final daily dose of 2.8 mg)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Enalapril (mean final daily dose of 12.6 mg)
Number of subjects: 160
Study: 8148213

Group type: EXPERIMENTAL
Intervention: High-fat breakfast (500 mg atovaquone)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Toast with 28 g butter (LOFAT)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Toast with 56 g butter (HIFAT)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Aqueous suspension of atovaquone
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Oily solution/suspension in miglyol
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: i.v. infusion of cholecystokinin octapeptide (CCK-OP)
Number of subjects: 47
Study: 3250830

Group type: EXPERIMENTAL
Intervention: Anticancer B
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Aminoretinoic Ester
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo (Starch)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Normal individuals
Number of subjects: 102

Group type: COMPARATOR
Intervention: Early esophageal cancer patients
Number of subjects: 102
Study: 31200560

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (2000 IU cholecalciferol/day for three months)
Number of subjects: 92

Group type: COMPARATOR
Intervention: No vitamin D supplementation (control group)
Number of subjects: 92
Study: 28068001

Group type: EXPERIMENTAL
Intervention: Ivacaftor
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 25788001

Group type: EXPERIMENTAL
Intervention: Orange juice (320 mg hesperidin)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Hesperidin supplement (320 mg hesperidin)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 16
Study: 23799963

Group type: EXPERIMENTAL
Intervention: Modified pre‐arrival instructions using patient's arm and nipple line as landmarks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group instructions: 'Kneel down beside the chest. Place one hand in the centre of the victim's chest and the other on top.'
Number of subjects: 36
Study: 21561346

Group type: EXPERIMENTAL
Intervention: Pneumatic dilation
Number of subjects: 201

Group type: COMPARATOR
Intervention: Laparoscopic Heller's myotomy (LHM)
Number of subjects: 201
Study: 19357539

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Warfarin (coumadin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonsteroidal antiinflammatory drugs (NSAIDs) or aspirin
Number of subjects: 0
Study: 16311263

Group type: EXPERIMENTAL
Intervention: Fluconazole 800 mg/day
Number of subjects: 9
Study: 15656360

Group type: EXPERIMENTAL
Intervention: Naphcon eye drops (3 times during 15 minutes before surgery)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no Naphcon eye drops)
Number of subjects: 100
Study: 10789746

Group type: EXPERIMENTAL
Intervention: Hemorrhoidectomy (Group A, n = 35)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Operative dilation with postoperative dilation program (Group B, n = 39)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Operative dilation without postoperative program (Group C, n = 44)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Anal dilation (Group B and C)
Number of subjects: 138
Study: 8752017

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 241

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 241
Study: 1421051

Group type: EXPERIMENTAL
Intervention: Teicoplanin 3 mg kg-1
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Teicoplanin 30 mg kg-1
Number of subjects: 13
Study: 4082753

Group type: EXPERIMENTAL
Intervention: 16 microgram dose of HBsAg vaccine
Number of subjects: 71
Study: 29433376

Group type: EXPERIMENTAL
Intervention: Pomegranate polyphenol supplementation (1 g of polyphenols, twice per day for one week)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (lactose pills, twice per day for one week)
Number of subjects: 16
Study: 29253180

Group type: EXPERIMENTAL
Intervention: Active music therapy intervention
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Passive music therapy intervention
Number of subjects: 40
Study: 26572094

Group type: EXPERIMENTAL
Intervention: Discussion-Based Learning (DBL)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Lecture-Based Learning (LBL)
Number of subjects: 27
Study: 25454818

Group type: EXPERIMENTAL
Intervention: NanoGen (nanocrystalline calcium sulfate bone graft)
Number of subjects: 60

Group type: COMPARATOR
Intervention: DentoGen (medical-grade calcium sulfate bone graft)
Number of subjects: 60
Study: 22842201

Group type: EXPERIMENTAL
Intervention: Staining solution (coffee) with AccessCrown material
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Staining solution (coffee) with Structur2 SC material
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Staining solution (coffee)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Distilled water (control group)
Number of subjects: 0
Study: 20818901

Group type: EXPERIMENTAL
Intervention: Sibutramine
Number of subjects: 10744

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10744
Study: 17322430

Group type: EXPERIMENTAL
Intervention: Alumina ceramic acetabular liner
Number of subjects: 50

Group type: COMPARATOR
Intervention: Polyethylene acetabular liner
Number of subjects: 50
Study: 16353041

Group type: EXPERIMENTAL
Intervention: Ticlopidine (TIC) 500 mg BID for 2 days and 250 mg BID for subsequent 5 days
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Clopidogrel (CL) 300 mg on day 1 and 75 mg/day for subsequent 6 days
Number of subjects: 56

Group type: COMPARATOR
Intervention: Ticlopidine (TIC)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Clopidogrel (CL)
Number of subjects: 56
Study: 11866268

Group type: COMPARATOR
Intervention: Control group (normal controls)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IBS group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IBD group
Number of subjects: 0
Study: 10201458

Group type: EXPERIMENTAL
Intervention: Dicyclomine (Dic) 20 mg four times daily
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (Pla)
Number of subjects: 15
Study: 9395592

Group type: EXPERIMENTAL
Intervention: HIV antibody testing, counseling and education programme
Number of subjects: 508

Group type: COMPARATOR
Intervention: Comparison group (no intervention)
Number of subjects: 508
Study: 1935475

Group type: EXPERIMENTAL
Intervention: CAA with reservoir and excision of the ATZ
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (6 controls, mean age, 65.8 years; 2 females and 4 males)
Number of subjects: 18
Study: 6130078

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 30717942

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention programme (six 90-min educational sessions, held weekly)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 108
Study: 28118298

Group type: EXPERIMENTAL
Intervention: Web-based physical activity promotion program
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 29
Study: 26911582

Group type: EXPERIMENTAL
Intervention: Intravenous exenatide for up to 72 hours
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard therapy (intravenous insulin)
Number of subjects: 30
Study: 24795284

Group type: EXPERIMENTAL
Intervention: NIRS (near-infrared spectroscopy) of frontal brain started after return of spontaneous circulation (ROSC) during admission to ICU and continued until normothermia
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: NIRS (near-infrared spectroscopy) of frontal brain
Number of subjects: 60
Study: 22487159

Group type: EXPERIMENTAL
Intervention: 80% VO(2peak) for 30 min (HIGH)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 50% VO(2peak) for 30 min (MOD)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 50% VO(2peak) for 60 min (MOD(L))
Number of subjects: 10
Study: 20480800

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.1% cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adapalene 0.3% gel
Number of subjects: 0
Study: 18823201

Group type: EXPERIMENTAL
Intervention: Withheld action plan based on identity of a stimulus (Experiment 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Withheld action plan based on identity of a stimulus (Experiment 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Withheld action plan based on identity of a stimulus (Experiment 3)
Number of subjects: 0
Study: 15661475

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation, 60 mg retinol equivalent every 3 months
Number of subjects: 181

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 181
Study: 12905653

Group type: EXPERIMENTAL
Intervention: Modified ultrafiltration (MUF)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional ultrafiltration (CUF)
Number of subjects: 30
Study: 10069275

Group type: EXPERIMENTAL
Intervention: Continuous infusion of sufentanil (3.6 microg/kg/h) and midazolam (0.08 mg/kg/h)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Bolus administration of sufentanil (2 microg/kg) and midazolam (0.03 mg/kg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Continuous infusion of sufentanil and midazolam
Number of subjects: 30

Group type: COMPARATOR
Intervention: Bolus administration of sufentanil and midazolam
Number of subjects: 30

Group type: COMPARATOR
Intervention: Bolus administration
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Continuous infusion
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Continuous infusion and bolus administration
Number of subjects: 30
Study: 7723338

Group type: EXPERIMENTAL
Intervention: Spirapril
Number of subjects: 18

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 18
Study: 2033418

Group type: EXPERIMENTAL
Intervention: Autologous bone marrow transplantation (pilot protocol POG 8340)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Any transplant (not specified)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Surgery plus conventional chemotherapy (POG 8441)
Number of subjects: 116
Study: 7315207

Group type: EXPERIMENTAL
Intervention: 3% metoprolol eye drops
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.5% timolol eye drops
Number of subjects: 0
Study: 31091292

Group type: EXPERIMENTAL
Intervention: Anti-bias language condition
Number of subjects: 4

Group type: COMPARATOR
Intervention: Standard evaluation instrument
Number of subjects: 4
Study: 25822106

Group type: EXPERIMENTAL
Intervention: Palonosetron (PALO) plus 1-day dexamethasone (DEX)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Fosaprepitant (FAPR), granisetron (GRAN), and DEX
Number of subjects: 35
Study: 23404447

Group type: EXPERIMENTAL
Intervention: Valganciclovir
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Valganciclovir (Val>6M)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Valganciclovir (0 or <6 months)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Contemporary controls
Number of subjects: 42
Study: 21054600

Group type: EXPERIMENTAL
Intervention: Mother's milk
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Sucrose
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Pacifier
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control
Number of subjects: 120
Study: 19701509

Group type: EXPERIMENTAL
Intervention: ozone + Clearfil Protect Bond
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: ozone + Xeno III
Number of subjects: 136

Group type: COMPARATOR
Intervention: Clearfil Protect Bond
Number of subjects: 136

Group type: COMPARATOR
Intervention: Xeno III
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: ozone + Clearfil Protect Bond (dentin)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: ozone + Xeno III (dentin)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Clearfil Protect Bond (dentin)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Xeno III (dentin)
Number of subjects: 136
Study: 17760696

Group type: EXPERIMENTAL
Intervention: Cleansing lotion containing tamarind fruit extract with 2% (w/w) tartaric acid
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo product
Number of subjects: 15

Group type: COMPARATOR
Intervention: De-ionized water
Number of subjects: 15
Study: 15061263

Group type: EXPERIMENTAL
Intervention: Protocol A (early 4 h imaging)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Protocol B (early and delayed 24 h imaging)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Protocol B (delayed imaging)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Protocol A (early high uptake intensity)
Number of subjects: 220
Study: 11475180

Group type: EXPERIMENTAL
Intervention: Group F + P + S (1.0 microgram/kg fentanyl and 0.5 mg/kg propofol prior to induction)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Group F + S (1.0 microgram/kg fentanyl prior to induction)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Group S (8% sevoflurane only)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Group F + P + S
Number of subjects: 120
Study: 9735664

Group type: EXPERIMENTAL
Intervention: Specialized columnar epithelium presence in patients with short segment columnar-lined esophagus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Specialized columnar epithelium presence in patients without columnar-lined esophagus
Number of subjects: 0
Study: 8052871

Group type: EXPERIMENTAL
Intervention: Carboplatin 300 mg/m2 day I, etoposide 140 mg/m2 days 1 through 3, and vincristine 1.4 mg/m2 days 1, 8, and 15 (CEV)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Etoposide 200 mg/m2 days 1 through 3 and vincristine 1.4 mg/m2 days 1 and 8 (EV)
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Carboplatin/etoposide/vincristine (CEV)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Etoposide/vincristine (EV)
Number of subjects: 317
Study: 1969017

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate and prostaglandin E1
Number of subjects: 0
Study: 478206

Group type: EXPERIMENTAL
Intervention: Domperidone (two 10‐mg tablets t.i.d. before meals)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (two 10‐mg tablets t.i.d. before meals)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Domperidone
Number of subjects: 32
Study: 31816417

Group type: EXPERIMENTAL
Intervention: Registered trials
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Prospectively registered trials
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Trials providing protocols
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Trials with larger enrollment numbers
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Trials with nonindustry funding
Number of subjects: 625
Study: 30102389

Group type: EXPERIMENTAL
Intervention: Valacyclovir for 6 months
Number of subjects: 38

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 38
Study: 28013058

Group type: EXPERIMENTAL
Intervention: Leg compressions
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 13
Study: 25530265

Group type: EXPERIMENTAL
Intervention: Micafungin 300 mg day(‐1) intravenous monotherapy
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control monotherapy (lipid amphotericin B 5 mg kg(‐1) day(‐1), voriconazole 8 mg kg(‐1) day(‐1), or caspofungin 50 mg day(‐1))
Number of subjects: 17
Study: 23113540

Group type: EXPERIMENTAL
Intervention: Porcine placental extract (PPE) for 24 weeks in climacteric women and 12 weeks in postmenopausal women with HT
Number of subjects: 66

Group type: COMPARATOR
Intervention: Toki-shakuyaku-san (TJ23; 7.5 g/day)
Number of subjects: 66
Study: 21285125

Group type: EXPERIMENTAL
Intervention: Losartan 0.7-1.4 mg/kg/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo/Amlodipine 0.1-0.2 mg/kg/day up to 5 mg/day
Number of subjects: 30
Study: 19739064

Group type: EXPERIMENTAL
Intervention: Training and child welfare intervention
Number of subjects: 25

Group type: COMPARATOR
Intervention: Training
Number of subjects: 25
Study: 17983260

Group type: EXPERIMENTAL
Intervention: Continuous-use ethinylestradiol/levonorgestrel 20μg/90μg
Number of subjects: 2134
Study: 15145879

Group type: EXPERIMENTAL
Intervention: Patients after atrial correction for TGA
Number of subjects: 27
Study: 11564203

Group type: EXPERIMENTAL
Intervention: Computer-assisted instruction (CAI)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Textbook (text group)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups (CAI and text)
Number of subjects: 80
Study: 9521830

Group type: EXPERIMENTAL
Intervention: Experimental memory tests for explicit information in DID subjects
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Experimental memory tests for implicit information in DID subjects
Number of subjects: 4
Study: 7820974

Group type: EXPERIMENTAL
Intervention: Beta-adrenergic inhibition with propranolol
Number of subjects: 7
Study: 3393382

Group type: EXPERIMENTAL
Intervention: Clenbuterol (0.001 mg/kg) administered 90 minutes before exercise test
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Clenbuterol (0.001 mg/kg) administered 300 minutes before exercise test
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Salbutamol (0.12 mg/kg) administered 90 minutes before exercise test
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Salbutamol (0.12 mg/kg) administered 300 minutes before exercise test
Number of subjects: 16
Study: 31286656

Group type: EXPERIMENTAL
Intervention: Arm I: Portable play equipment added to the school environment
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Arm II: Portable play equipment plus PA education for staff and children
Number of subjects: 97
Study: 29096833

Group type: EXPERIMENTAL
Intervention: Specific Lp(a) apheresis
Number of subjects: 15

Group type: COMPARATOR
Intervention: Atorvastatin monotherapy (Control)
Number of subjects: 15
Study: 26583658

Group type: EXPERIMENTAL
Intervention: Laparoscopic mesh-augmented hiatoplasty with cardiophrenicopexy (LMAH-C)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Laparoscopic Nissen fundoplication (LNF)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: LMAH-C
Number of subjects: 90

Group type: COMPARATOR
Intervention: LNF
Number of subjects: 90
Study: 23537979

Group type: EXPERIMENTAL
Intervention: rosiglitazone
Number of subjects: 111

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 111
Study: 21668938

Group type: EXPERIMENTAL
Intervention: C6 injection
Number of subjects: 60

Group type: COMPARATOR
Intervention: C5 injection
Number of subjects: 60
Study: 19840639

Group type: EXPERIMENTAL
Intervention: ProTaper Obturators (PTO)
Number of subjects: 8

Group type: COMPARATOR
Intervention: System‐B/Calamus (SBC)
Number of subjects: 8
Study: 17040590

Group type: EXPERIMENTAL
Intervention: Mitomycin C applied topically post-operatively in FESS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control side (no mitomycin C)
Number of subjects: 30
Study: 15319017

Group type: EXPERIMENTAL
Intervention: BID MPH for 7 days a week
Number of subjects: 40

Group type: COMPARATOR
Intervention: BID MPH on weekdays and placebo on weekends
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Omission of MPH on weekends
Number of subjects: 40
Study: 10764680

Group type: EXPERIMENTAL
Intervention: Peroral estradiol valerate (2 mg/d)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol gel (1 mg/d)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Both therapies
Number of subjects: 79
Study: 9331308

Group type: EXPERIMENTAL
Intervention: Home intravenous (IV) hydration after tonsillectomy
Number of subjects: 100

Group type: COMPARATOR
Intervention: No home intravenous (IV) hydration after tonsillectomy
Number of subjects: 100
Study: 8453962

Group type: EXPERIMENTAL
Intervention: Oxprenolol taken orally at 08.00 h
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oxprenolol taken orally at 14.00 h
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oxprenolol taken orally at 20.00 h
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oxprenolol taken orally at 02.00 h
Number of subjects: 6
Study: 2429834

Group type: EXPERIMENTAL
Intervention: Epidural blockade
Number of subjects: 60

Group type: COMPARATOR
Intervention: Neurolept anaesthesia
Number of subjects: 60